S&P 500
(-0.46%) 5 048.42 points
Dow Jones
(-0.98%) 38 086 points
Nasdaq
(-0.64%) 15 612 points
Oil
(0.28%) $83.80
Gas
(-2.26%) $1.601
Gold
(0.09%) $2 344.70
Silver
(0.35%) $27.45
Platinum
(0.76%) $927.50
USD/EUR
(-0.26%) $0.932
USD/NOK
(-0.17%) $10.96
USD/GBP
(-0.39%) $0.799
USD/RUB
(-0.16%) $92.17

Realtime updates for Cohen & Steers Global [GRI]

Exchange: ETF
Last Updated25 Apr 2024 @ 16:00

-1.65% $ 0.430

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

GRI Bio, Inc., a development stage biotech company, develops Natural Killer T (NKT) cell-based therapies for liver disease and autoimmunity. Its program includes GRI-0621, an inhibitor of type 1 NKT cells that is developed as an oral therapeutic for liver disease...

Stats
Today's Volume 25 038.00
Average Volume 773 058
Market Cap 1.38M
EPS $0 ( 2024-04-05 )
Next earnings date ( $0 ) 2024-05-13
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0200
ATR14 $0.00600 (1.39%)

Volume Correlation

Long: -0.18 (neutral)
Short: -0.47 (neutral)
Signal:(50.364) Neutral

Cohen & Steers Global Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cohen & Steers Global Correlation - Currency/Commodity

The country flag 0.17
( neutral )
The country flag 0.27
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.10
( neutral )

Cohen & Steers Global Financials

Annual 2023
Revenue: $0
Gross Profit: $-57 000.00 (0.00 %)
EPS: $-28.25
Q4 2023
Revenue: $5.39M
Gross Profit: $5.38M (99.72 %)
EPS: $-3.10
Q3 2023
Revenue: $0
Gross Profit: $-1 000.00 (0.00 %)
EPS: $-3.63
Q2 2023
Revenue: $0
Gross Profit: $-2 000.00 (0.00 %)
EPS: $-19.53

Financial Reports:

No articles found.

Cohen & Steers Global

GRI Bio, Inc., a development stage biotech company, develops Natural Killer T (NKT) cell-based therapies for liver disease and autoimmunity. Its program includes GRI-0621, an inhibitor of type 1 NKT cells that is developed as an oral therapeutic for liver disease. GRI Bio, Inc. was formerly know as Glycoregimmune, Inc. GRI Bio, Inc. was incorporated in 2009 and is based in LA Jolla, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators